Market incentives, human lives, and AIDS vaccines.
暂无分享,去创建一个
[1] P. Bourdieu,et al. Acts of resistance : against tyranny of the market , 1998 .
[2] D. Bok. Universities in the Marketplace: The Commercialization of Higher Education , 2003 .
[3] N. Thrift. Environment and Planning D: Society and Space , 1995 .
[4] Charal Trinvuthipong. Thailand's Prime-Boost HIV Vaccine Phase III , 2004, Science.
[5] R. Zinkernagel. The Challenges of an HIV Vaccine Enterprise , 2004, Science.
[6] J. Clapp,et al. Development as freedom , 1999 .
[7] S. Shiffman,et al. Recent advances in the pharmacotherapy of smoking. , 1999, JAMA.
[8] D. Harvey. Spaces of Hope , 2000 .
[9] R. Desrosiers. Prospects for an AIDS vaccine , 2004, Nature Medicine.
[10] B. Loff,et al. Patents on Drugs: Manufacturing Scarcity or Advancing Health? , 2002, Journal of Law, Medicine & Ethics.
[11] Yiming Shao,et al. Enhanced: The Need for a Global HIV Vaccine Enterprise , 2003, Science.
[12] Richard A. Falk,et al. Human Rights Horizons: The Pursuit of Justice in a Globalizing World , 2000 .
[13] M. Angell. The Truth About the Drug Companies: How They Deceive Us and What to Do About It , 2004 .
[14] J. Kahn. Getting the Numbers Right: Statistical Mischief and Racial Profiling in Heart Failure Research , 2003, Perspectives in biology and medicine.
[15] Jayati Ghosh,et al. HIV and AIDS in Africa: beyond epidemiology. , 2004 .
[16] J. Galbraith. A perfect crime: inequality in an age of globalization , 2002 .
[17] P. Farmer. Pathologies of Power , 2019 .
[18] C. Collins,et al. HIV vaccine research and human rights: examples from three countries planning efficacy trials. , 1998, Health and human rights.
[19] Jon Cohen. Shots in the dark: the wayward search for the AIDS vaccine. , 2001 .
[20] Paul Farmer,et al. Infections and inequalities : the modern plagues , 2001 .
[21] J. Glassman. From Seattle (and Ubon) to Bangkok: The Scales of Resistance to Corporate Globalization , 2002 .
[22] S. Berkley. The International AIDS Vaccine Initiative. , 1997, Journal of the International Association of Physicians in AIDS Care.
[23] W. Muraskin. The Politics of International Health: The Children's Vaccine Initiative and the Struggle to Develop Vaccines for the Third World , 1998 .
[24] Merrill Goozner,et al. The $800 Million Pill: The Truth behind the Cost of New Drugs , 2004 .
[25] Timothy Mitchell,et al. Rule of Experts: Egypt, Techno-Politics, Modernity , 2002 .
[26] J. Gibson‐Graham. The End Of Capitalism (As We Knew It): A Feminist Critique of Political Economy , 1996 .
[27] J. Lieberman,et al. A Sound Rationale Needed for Phase III HIV-1 Vaccine Trials , 2004, Science.
[28] A. Gelijns,et al. Medical innovation and institutional interdependence: rethinking university-industry connections. , 2002, JAMA.
[29] S. Krimsky,et al. Science in the private interest: has the lure of profits corrupted biomedical research? , 2006, IEEE Technology and Society Magazine.
[30] C. Thomas. Trade policy and the politics of access to drugs , 2002 .
[31] M. Heywood. Drug access, patents and global health: 'Chaffed and waxed sufficient' , 2002 .